Analogues of atriopeptin(103-125)amide having high binding selectivity.

J Med Chem

Cardiovascular Diseases Research Department, Searle Research and Development Division, G. D. Searle and Company, Chesterfield, Missouri 63198.

Published: May 1989

Analogues of atriopeptin(103-125)amide were prepared having a disulfide bridge at positions different from that found in the natural product. Most of these conformationally perturbed peptides were found to bind selectively to one subclass of binding sites. Binding affinity to a class of specific binding sites that is not associated with any known biological activity (nonvasorelaxant or NVR binding sites) is unaffected or even modestly improved. Affinity for the receptor subclass that is associated with vasorelaxation (VR subclass) decreases in most examples. In several cases, binding to the VR subclass is below the limits of detection for the assay used here. The data demonstrate that binding of atrial peptides to VR receptors requires rigidly defined receptor/ligand interactions. In contrast, the NVR subclass of binding sites appears to tolerate changes in peptide structure quite well.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm00125a026DOI Listing

Publication Analysis

Top Keywords

binding sites
16
analogues atriopeptin103-125amide
8
binding
8
subclass binding
8
subclass
5
atriopeptin103-125amide high
4
high binding
4
binding selectivity
4
selectivity analogues
4
atriopeptin103-125amide prepared
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!